USPTO serial 79100256
GENIDUNN
Reviewed by CopyMark Law Group
Reg. 4196388Status 404
- Filing date
- Status date
- Registration date
- Aug 28, 2012
- Examiner
- GARTNER, JOHN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENIDUNN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
CN
Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
CN
Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
CN
Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Hair lotions; cleansing milk for toilet purposes; shampoos; cakes of soap; hair conditioner; facial washing milk; bath lotion; beauty masks; cosmetics; hair-blackening cream; medicated soap; bath salts; fragrant essential oils; anti-wrinkle cream; skin whitening cream; non-medicated acne treatment creams; macule-removing skin cream; hair tonic; skin whitening creams | SECTION 71 - CANCELLED | — |
| 005 | Antiallergic medicines; medicines for the treatment of gastrointestinal diseases; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ginseng electuary, namely, confectionery for medicinal purposes; ginseng for medical use; capsules sold empty for pharmaceuticals; medicinal herbs; herbs teas for medicinal purposes; by-products of the processing of cereals for medical purposes; preparations of trace elements for human and animal use, namely, dietary supplements; amino acids for medical purposes; aqueous formulation, namely, cleansing solutions for medical use; encapsulated pills for delivery of pharmaceuticals sold without the pharmaceutical ingredient; medicinal alcohol; pharmaceutical preparations for skin care; bath preparations, medicated; dietetic foods adapted for medical purposes; food for babies; dietetic beverages adapted for medical purposes; dietetic sugar adapted for medical use; mineral food-supplements; nutritional additives for medical purposes used in foods and dietary supplements for human consumption; bag filled with Chinese medicine, namely, a medicine kit consisting of medicinal herbs; vitamin preparations; medicated sunburn ointments; medicinal hair growth preparations; dietary and nutritional supplements; dietary and nutritional supplements containing nut oil, fish oil; dietary and nutritional supplements for endurance sports; dietary and nutritional supplements used for weight loss; liquid nutritional supplement; mineral nutritional supplements; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables; nutritional supplements; nutritional supplements for boosting energy, promoting healthy skin; nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels | SECTION 71 - CANCELLED | — |
| 030 | Tea substitute; nutritional supplement in the form of solution, cream, powder or capsule, namely, wheat germ and curry pastes; condiments, namely, mustard; flavorings, other than essential oils; relish; aromatic preparations for food, namely, flavoring; cereal preparations, namely, processed cereals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
- Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
- Other trademarks owned by YUNNAN HERBESSENCES BIOTECHNOLOGY CO., LTD.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 030
- Similar marks named GENIDUNN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 7, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 24, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 31, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 31, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 29, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 29, 2019 | C71T | CANCELLED SECTION 71 | — |
| Dec 14, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 2, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 29, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 29, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 28, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 23, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 23, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| May 9, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 7, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 11, 2012 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 15, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 22, 2012 | NREV | NOTICE OF REVIVAL - MAILED | — |
| Feb 22, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2012 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 22, 2012 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Sep 11, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 19, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 18, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 17, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 8, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |